ClinVar Genomic variation as it relates to human health
NM_024757.5(EHMT1):c.871C>T (p.Arg291Ter)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_024757.5(EHMT1):c.871C>T (p.Arg291Ter)
Variation ID: 3608 Accession: VCV000003608.7
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 9q34.3 9: 137743418 (GRCh38) [ NCBI UCSC ] 9: 140637870 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Oct 1, 2013 Oct 8, 2024 May 6, 2022 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_024757.5:c.871C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_079033.4:p.Arg291Ter nonsense NM_001145527.2:c.871C>T NP_001138999.1:p.Arg291Ter nonsense NM_001354259.2:c.778C>T NP_001341188.1:p.Arg260Ter nonsense NM_001354263.2:c.850C>T NP_001341192.1:p.Arg284Ter nonsense NM_001354611.2:c.871C>T NP_001341540.1:p.Arg291Ter nonsense NM_001354612.2:c.778C>T NP_001341541.1:p.Arg260Ter nonsense NC_000009.12:g.137743418C>T NC_000009.11:g.140637870C>T NG_011776.1:g.129427C>T - Protein change
- R260*, R291*, R284*
- Other names
- -
- Canonical SPDI
- NC_000009.12:137743417:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
EHMT1 | Sufficient evidence for dosage pathogenicity | Little evidence for dosage pathogenicity |
GRCh38 GRCh37 |
2084 | 2394 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (5) |
criteria provided, multiple submitters, no conflicts
|
May 6, 2022 | RCV000003792.10 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Sep 01, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Kleefstra syndrome 1
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
germline
|
Baylor Genetics
Accession: SCV000807330.2
First in ClinVar: Nov 17, 2017 Last updated: Dec 11, 2022 |
Comment:
This mutation has been previously reported as disease-causing and was found twice in our laboratory in unrelated probands: a 2-year-old male with developmental delay, hypotonia, … (more)
This mutation has been previously reported as disease-causing and was found twice in our laboratory in unrelated probands: a 2-year-old male with developmental delay, hypotonia, poor coordination, microcephaly, dysmorphism; & de novo in a 1-year-old male with global delays, dysmorphisms, advanced bone age. (less)
|
|
Pathogenic
(-)
|
criteria provided, single submitter
Method: curation
|
Kleefstra syndrome 1
Affected status: yes
Allele origin:
de novo
|
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Accession: SCV005045847.1
First in ClinVar: Oct 08, 2024 Last updated: Oct 08, 2024
Comment:
de novo
|
|
|
Pathogenic
(May 06, 2022)
|
criteria provided, single submitter
Method: research
|
Kleefstra syndrome 1
Affected status: yes
Allele origin:
de novo
|
HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology
Study: HudsonAlpha-AGHI-WGS
Accession: SCV002515841.1 First in ClinVar: May 21, 2022 Last updated: May 21, 2022 |
Comment:
ACMG codes: PVS1_Strong, PS2, PS4M, PM2
Number of individuals with the variant: 1
Clinical Features:
Macroglossia (present) , Full cheeks (present) , Micrognathia (present) , Anteverted nares (present) , Eczematoid dermatitis (present) , Global developmental delay (present) , Dysphagia (present) … (more)
Macroglossia (present) , Full cheeks (present) , Micrognathia (present) , Anteverted nares (present) , Eczematoid dermatitis (present) , Global developmental delay (present) , Dysphagia (present) , Tracheomalacia (present) (less)
|
|
Pathogenic
(Sep 01, 2009)
|
no assertion criteria provided
Method: literature only
|
KLEEFSTRA SYNDROME 1
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000023957.4
First in ClinVar: Apr 04, 2013 Last updated: Sep 27, 2020 |
Comment on evidence:
In a 19-year-old man (patient 19) with a phenotype consistent with chromosome 9q subtelomeric deletion syndrome (KLEFS1; 610253), Kleefstra et al. (2009) identified a de … (more)
In a 19-year-old man (patient 19) with a phenotype consistent with chromosome 9q subtelomeric deletion syndrome (KLEFS1; 610253), Kleefstra et al. (2009) identified a de novo heterozygous c.778C-T transition (c.778C-T, NM_024757.3) in the EHMT1 gene, resulting in an arg260-to-ter (R260X) substitution, predicted to result in nonsense-mediated mRNA decay. The man had mental retardation, seizures, and characteristic facial abnormalities. (less)
|
|
not provided
(-)
|
no classification provided
Method: literature only
|
Kleefstra syndrome 1
Affected status: not provided
Allele origin:
unknown
|
GeneReviews
Accession: SCV000087011.2
First in ClinVar: Oct 01, 2013 Last updated: Oct 01, 2022 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome. | Rots D | American journal of human genetics | 2024 | PMID: 39013458 |
Kleefstra Syndrome. | Adam MP | - | 2023 | PMID: 20945554 |
Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype. | Kleefstra T | Journal of medical genetics | 2009 | PMID: 19264732 |
Text-mined citations for rs137852714 ...
HelpRecord last updated Oct 08, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.